Full discussion of the HTA results

  • Gudrun Bornhöft
  • Klaus v. Ammon
  • Marco Righetti
  • André Thuneysen
  • Peter F. Matthiessen

Abstract

It was the task of the present HTA to evaluate, within the PEK context, the efficacy, appropriateness (in terms of demand and safety) and economy of homeopathy. For this purpose the situation in Switzerland had to be assessed and reflected as realistically as possible.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alderson P, Green S, Higgins J. Cochrane Reviewers’ Handbook. Handbook 4.2.1. [updated December 2003]. Chichester: John Wiley & Sons Ltd, 2004Google Scholar
  2. Altman DG, Bland JM. Absence of evidence is not evidence of absence. British Medical Journal 1995;311:485PubMedGoogle Scholar
  3. Chaufferin G. Improving the evaluation of homeopathy: economic considerations and impact on health. British Homeopathic Journal 2000;89(1):27–30CrossRefGoogle Scholar
  4. Cucherat M, Haugh MC, Gooch M, Boissel JP. Evidence of clinical efficacy of homeopathy (A meta-analysis of clinical trials). European Journal of Clinical Pharmacology 2000;56:27–33PubMedCrossRefGoogle Scholar
  5. Glanville J, Sowden A. Identification of the need for a review. In: Khan K, ter Riet G, Glanville J, Sowden A, Kleijnen J (editors). Undertaking Systematic Reviews of Research on Effectiveness. CRD Report Number 4 (2nd Edition), York, 2001Google Scholar
  6. Güthlin C, Walach H. Prospektive Dokumentationsstudie in der niedergelassenen Praxis – ein Erprobungsverfahren zur Akupunktur und Homöopathie. Erfahrungsheilkunde 2001;(50):186–94CrossRefGoogle Scholar
  7. Güthlin C, Lange O, Walach H. Measuring the effects of acupuncture and homeopathy in general practice: An uncontrolled prospective documentation approach. BMC Public Health 2004;4(6).PubMedCrossRefGoogle Scholar
  8. Heusser P. Komplementärmedizin in der Grundversicherung: Verteuert sie die Gesundheitskosten? Schweizerische Zeitschrift für GanzheitsMedizin 1999;11 :4–9Google Scholar
  9. Jenny S, Simon M, Meier B. Haltung der Bevölkerung gegenüber der Komplementärmedizin Schweizerische Zeitschrift für GanzheitsMedizin 2002;14:340–7Google Scholar
  10. Kienle G. Arzneimittelsicherheit und Gesellschaft. Eine kritische Untersuchung. Stuttgart New York: Schattauer, 1974Google Scholar
  11. Kienle GS, Kiene H. Können aus der Studie „Komplementärmedizin in der Krankenversicherung“ wissenschaftlich tragfähige Schlüsse gezogen werden? Forschende Komplementärmedizin 1999;6(5):262–70PubMedCrossRefGoogle Scholar
  12. Kienle GS, Kiene H, Albonico HU. Anthroposophic Medicine. Effectiveness, utility, costs, safety. Stuttgart New York: Schattauer 2006bGoogle Scholar
  13. Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homeopathy. British Medical Journal 1991;302(6772):316–23.PubMedCrossRefGoogle Scholar
  14. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997;350(9081):834–43.PubMedCrossRefGoogle Scholar
  15. Linde K, Melchart D: Randomized controlled trials of individual homeopathy: a state-of-the-art review. The Journal of Alternative and Complementary Medicine 1998;4(4):371–388PubMedCrossRefGoogle Scholar
  16. Lüdtke R, Rutten ALB. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. Journal of Clinical Epidemiology. 2008; 61 (12):1197–1204.PubMedCrossRefGoogle Scholar
  17. Marstedt G, Moebus S. Gesundheitsberichterstattung des Bundes Heft 9: Inanspruchnahme alternativer Methoden in der Medizin. Berlin: Verlag Robert Koch Institut, 2002Google Scholar
  18. Mathie RT: The research ecidence base for homeopathy: a fresh assessment of the literature. Homeopathy 2003; 92(2):84–91PubMedCrossRefGoogle Scholar
  19. Niroomand F. Evidenzbasierte Medizin: Das Individuum bleibt auf der Strecke. Deutsches Ärzteblatt 2004; 101(26):1870–4Google Scholar
  20. Rutten AL, Stolper, CF. The 2005 meta-analysis of homeopathy: the importance of post-publication data. Homeopathy. 2008;97(4):169–77PubMedCrossRefGoogle Scholar
  21. Schüppel R. Kosten und Nutzen der Homöopathie - Ein echtes Schnäppchen? Der Hausarzt 2003;19:64Google Scholar
  22. Shang A, Huwiler-Muntener K, Nartey L et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366:726–732PubMedCrossRefGoogle Scholar
  23. SIGN 50 (Scottish Intercollegiate Guidelines Network). A guideline developer‘s handbook. Notes on the use of Methodology Checklist 2: Randomized Controlled Trials. 2005. available at: http://www.sign.ac.uk/guidelines/fulltext/50/notes2.html
  24. Sommer JH, Burgi M, Theiss R. Inclusion of complementary medicine increases health costs. Focus on Alternative & Complementary Therapies 1999;4(4):183–4Google Scholar
  25. Taieb C, Myon E. The economic impact of homeopathic management: the french example. Value Health 2003; 6(3):373CrossRefGoogle Scholar
  26. Trichard M, Chaufferin G, Nicoloyannis N. Pharmacoeconomic comparison between two drug stragegies of treatment of anxiety disorders: homeopathy and psychotropics (ISPOR Poster PMH23). Value in Health 2003; 6(3):350–1CrossRefGoogle Scholar
  27. Walach H. Unspezifische Therapie-Effekte – Das Beispiel Homöopathie. Habilitationsschrift Psychologisches Institut, Albert-Ludwigs-Universität Freiburg, 1997Google Scholar
  28. Wegscheider K. Was sind faire Vergleiche zwischen Therapien? Zeitschrift für ärztliche Fortbildung und Qualität im Gesundheitswesen 2005;99(4–5):275–8PubMedGoogle Scholar
  29. Wein C. Qualitätsaspekte klinischer Studien zur Homöopathie. Essen: KVC-Verlag, 2002Google Scholar
  30. World Medical Association, Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bulletin of the World Health Organization, 2001;79(4):373–4. available at: http://whqlibdoc.who.int/bulletin/2001/issue4/79(4)declaration.pdf

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Gudrun Bornhöft
    • 1
  • Klaus v. Ammon
    • 2
  • Marco Righetti
    • 3
  • André Thuneysen
    • 4
  • Peter F. Matthiessen
    • 5
  1. 1.Goslar
  2. 2.Institute of Complementary Medicine KIKOMUniversity of Bern Imhoof-Pavillon, InselspitalBern
  3. 3.ZürichAustria and Switzerland
  4. 4.Centre de Santé La CorbièreEstavayer-le-Lac
  5. 5.Zentrum für Integrative MedizinUniversität Witten/Herdecke gGmbHHerdecke

Personalised recommendations